Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
In-home COPD management program cuts 30-day acute-care readmissions
By
Alicia Lasek (f3)
Jun 29, 2022
Thirty-day readmission rates were 12% for post-acute COPD participants in an at-home pulmonary rehab program, and 22% for those without the intervention, a new study finds.
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
More clinical benefits of molnupiravir ID’d in COVID-19
Jun 07, 2022
New benefits for certain COVID-19 patients, including reduced need for respiratory intervention, have been found for Merck’s COVID-19 pill molnupiravir.
New study links sarcopenic obesity to dementia; experts call for preventive action
By
Alicia Lasek (f3)
May 26, 2022
Obesity with decreased muscle mass and function is prevalent in older adults and is tied to a high risk of dementia, researchers say.
‘No reliable evidence’ for most antidepressants in relief of long-term pain, review finds
By
Alicia Lasek
May 18, 2023
With the exception of duloxetine, there is not enough reliable evidence to support the use of most antidepressant medications in the relief of chronic pain, a new review and meta-analysis has shown.
At-home COVID-19 tests get a $70M boost as feds push to increase access
By
Alicia Lasek
Oct 27, 2021
The Biden Administration is streamlining the process to bring new tests to market among other moves designed to increase testing supplies and access.
CDC says COVID-19 vaccine boosters not yet necessary, while Pfizer seeks approval for third dose
By
Alicia Lasek
Jul 12, 2021
Fully vaccinated Americans do not need a COVID-19 booster shot at this time, according to federal health officials. But Pfizer has asked to offer a third dose of its current vaccine and is developing an...
Risk of respiratory infection nearly 6 times higher in people with insomnia
By
Alicia Lasek
Jun 09, 2023
Chronic poor sleep is a risk factor for contracting influenza and other respiratory infections, and contributes to severity, a large study reveals.